The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage ...

Jan 9 (Reuters) - Ocugen Inc OCGN.O said on Monday the COVID-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States, sending ...

Bharat Biotech International Ltd has started clinical trials of the Tuberculosis vaccine MTBVAC on adults in India, the company said on Sunday. As per Bharat Biotech, MTBVAC is the first vaccine ...

Bharat, GSK to halve price of malaria vaccine by 2028 Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, ...

Prime Minister Narendra Modi is expected to visit Hyderabad-based Bharat Biotech International, the leading vaccine manufacturer in India, to review the process of COVID-19 vaccine production on ...

The Central Drugs Standard Control Organisation (CDSCO) has declared a batch of Typbar, the typhoid polysaccharide vaccine from Bharat Biotech International Ltd as not of standard quality (NSQ). The ...

Dr Krishna M Ella, co-founder and executive chairman of Bharat Biotech International, a company known more for its Covaxin Covid vaccine, sees the budget as unique for the multitude of measures that, ...

Article ‘Count’ and ‘Share’ for Bharat Biotech International Limited based on listed parameters only. The articles listed below published by authors from Bharat Biotech International Limited, ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: COVID-19 vaccination in New Delhi (Reuters) -Ocugen Inc said on Monday the COVID-19 vaccine developed by its Indian ...